Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Name: Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
SKU: pb-42-1-feusner
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-42-1-feusner Categories: Psychopharmacology Bulletin, VOL 42 No. 1 Articles Tags: alexander-bystritsky, generalized-anxiety-disorder, glutamate, jamie-d-feusner, lauren-kerwin, medworks-media, memantine, nmda-receptor, no-1, obsessive-compulsive-disorder, psychopharmacology-bulletin, sanjaya-saxena, volume-42

Description

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

MWM-PSB-42-01-2009-FEUSNER

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Antipsychotics Case Study by Yuan-Hwa Chou

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Related products

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Antipsychotics Case Study by Yuan-Hwa Chou

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason